CI Stock Recent News
CI LATEST HEADLINES
Investors with an interest in Medical - HMOs stocks have likely encountered both Cigna (CI) and Humana (HUM). But which of these two stocks is more attractive to value investors?
The recent uptick in U.S. manufacturing signals a promising trend for the economy. Investor confidence in the economy's stability is reflected in the decreasing odds for a June rate cut, indicating optimism about future monetary policy.
CNBC's Bertha Coombs reports on what's driving health insurer stocks lower.
Cigna (CI) reachead $363.34 at the closing of the latest trading day, reflecting a +1.57% change compared to its last close.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
We have narrowed our search to five non-tech S&P 500 stocks that have provided double-digit returns year to date. These are: CI, RL, PH, ETN, EBAY.
In the most recent trading session, Cigna (CI) closed at $352.63, indicating a +0.16% shift from the previous trading day.
Investors looking for stocks in the Medical - HMOs sector might want to consider either Cigna (CI) or Humana (HUM). But which of these two stocks offers value investors a better bang for their buck right now?